Concepedia

Karyopharm Therapeutics (United States)

KT

Statistics

Publications

799

Citations

85.9K

Authors

49

Location

Newton, United States

Karyopharm Therapeutics (United States) is a company institution in Newton, United States known for medicine, cell biology, and tumor biology.

HomepageROR

Top concepts

Publications

799

Genomic and molecular characterization of esophageal squamous cell carcinoma

De‐Chen Lin, Jia‐Jie Hao, Yasunobu Nagata et al. · Nature Genetics · 2014 · 656 citations · Full text

, , +6

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 655 citations · Full text

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 515 citations · Full text

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 371 citations · Full text

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo et al. · The Lancet Haematology · 2020 · 324 citations · Full text

, , +4

1–5 of 799

Authors

49

  1. SS
    Sharon Shacham

    Karyopharm Therapeutics (United States), United States

    560 publications · 12.3K citations

    62

    h-index

  2. MK
    Michael Kauffman

    Karyopharm Therapeutics (United States), United States

    431 publications · 13.5K citations

    55

    h-index

  3. YL
    Yosef Landesman

    Karyopharm Therapeutics (United States), United States

    450 publications · 6.8K citations

    45

    h-index

  4. EB
    Erkan Baloglu

    Karyopharm Therapeutics (United States), United States

    228 publications · 5.3K citations

    37

    h-index

  5. WS
    William Senapedis

    Karyopharm Therapeutics (United States), United States

    203 publications · 3.6K citations

    34

    h-index

1–5 of 49